Significantly, the non-canonical NF-κB pathway plays a key role in interactions between MM cells and the microenvironment (e.g., via BAFF, APRIL, CD40), which contributes to MM drug resistance [22]. This evidence concerns the gene CD40 and Miyoshi myopathy.